This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by ten Dam, V. H. Search for Related Content PubMed PubMed Citation Articles by ten Dam, V. H. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB CHOLESTEROL Medline Plus Health Information Statins Related Collections Computerized tomography and Magnetic Resonance Imaging Other Stroke Treatment - Medical

(Stroke. 2005;36:1633.)
© 2005 American Heart Association, Inc.

Original Contributions

Lack of Effect of Pravastatin on Cerebral Blood Flow or Parenchymal Volume Loss in Elderly at Risk for Vascular Disease

V. Hester ten Dam, MD; Frieke M.A Box, MSc; Anton J.M. de Craen, PhD; Dominique M.J. van den Heuvel, MSc; Edward L.E.M. Bollen, MD, PhD; Heather M. Murray, MSc; Mark A. van Buchem, MD, PhD; Rudi G.J. Westendorp, MD, PhD; Gerard Jan Blauw, MD, PhD on behalf of the PROSPER Study Group^*

From the Departments of Gerontology and Geriatrics (V.H.t.D., A.J.M.d.C., R.G.J.W., G.JB.), Radiology (F.M.A.B., D.M.J.v.d.H., M.A.v.B.), and Neurology (E.L.E.M.B.), Leiden University Medical Center, Leiden, The Netherlands; and the Robertson Centre for Biostatistics (H.M.M.), University of Glasgow, Glasgow, Scotland.

Correspondence to Dr G.J. Blauw, MD, PhD, Study Center for Gerontology and Geriatrics, Leiden University Medical Center, Rijnsburgerweg 10, Poortgebouw, 2333 AA Leiden, the Netherlands. E-mail g.j.blauw{at}lumc.nl

Background and Purpose— Ageing is associated with a decline in cerebral blood flow. Animal studies have shown that cholesterol-lowering therapy with statins might preserve cerebral blood flow (CBF). We examined the effect of 40 mg pravastatin on the decline in CBF and brain volume in a subset of elderly subjects participating in the PROspective Study of Pravastatin in the Elderly at Risk (PROSPER) trial.

Methods— Randomization was not stratified according to whether or not subjects participated in the MRI substudy. In 391 men (n=226) and women (n=165) aged 70 to 82 years (mean±SD, 75±3.2), we measured total CBF (in mL/min) at baseline and after a mean±SD follow-up of 33±1.4 months with a gradient-echo phase-contrast MRI technique. Total CBF was defined as the summed flows in both internal carotid and vertebral arteries. Parenchymal volume (whole brain) was segmented with the use of in-house–developed semiautomatic software.

Results— Total CBF significantly declined in the placebo-allocated group, from 521±83 to 504±92 mL/min (P=0.0036) and in the pravastatin-allocated group from 520±94 to 506±92 mL/min (P=0.018). This decline was not significantly different between treatment groups (P=0.56). There was also a significant reduction in brain volume over time (P<0.001), which was not different between the treatment groups (P=0.47). When expressed per unit of parenchymal volume, the decline in CBF over time was no longer statistically significant.

Conclusions— Elderly people at risk for cerebral vascular disease had a significant decline in CBF with increasing age that was explained by a concomitant reduction in brain volume. Treatment with 40 mg pravastatin daily had no beneficial effect on total CBF.

Key Words: cerebral blood flow • elderly • statins

This article has been cited by other articles:

				R. Schmidt, K. Petrovic, S. Ropele, C. Enzinger, and F. Fazekas Progression of Leukoaraiosis and Cognition Stroke, September 1, 2007; 38(9): 2619 - 2625. [Abstract] [Full Text] [PDF]

				V. H. ten Dam, D. M. J. van den Heuvel, A. J. M. de Craen, E. L. E. M. Bollen, H. M. Murray, R. G. J. Westendorp, G. J. Blauw, and M. A. van Buchem Decline in Total Cerebral Blood Flow Is Linked with Increase in Periventricular but Not Deep White Matter Hyperintensities Radiology, April 1, 2007; 243(1): 198 - 203. [Abstract] [Full Text] [PDF]

				F. J. Carod-Artal Statins and Cerebral Vasomotor Reactivity: Implications for a New Therapy? Stroke, October 1, 2006; 37(10): 2446 - 2448. [Full Text] [PDF]